Douglas Godshall - May 11, 2022 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Signature
/s/ Wade Estey, as attorney-in-fact for Douglas Godshall
Stock symbol
SWAV
Transactions as of
May 11, 2022
Transactions value $
-$2,061,807
Form type
4
Date filed
5/12/2022, 08:15 PM
Previous filing
Nov 21, 2023
Next filing
May 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $51.2K +15K +10.49% $3.42* 158K May 11, 2022 Direct F1
transaction SWAV Common Stock Sale -$40.3K -300 -0.19% $134.28 158K May 11, 2022 Direct F1, F2
transaction SWAV Common Stock Sale -$207K -1.52K -0.97% $136.09 156K May 11, 2022 Direct F1, F3
transaction SWAV Common Stock Sale -$210K -1.54K -0.99% $136.84 155K May 11, 2022 Direct F1, F4
transaction SWAV Common Stock Sale -$171K -1.24K -0.8% $137.62 153K May 11, 2022 Direct F1, F5
transaction SWAV Common Stock Sale -$181K -1.3K -0.85% $139.00 152K May 11, 2022 Direct F1, F6
transaction SWAV Common Stock Sale -$434K -3.1K -2.04% $140.03 149K May 11, 2022 Direct F1, F7
transaction SWAV Common Stock Sale -$127K -900 -0.6% $140.84 148K May 11, 2022 Direct F1, F8
transaction SWAV Common Stock Sale -$42.6K -300 -0.2% $142.10 148K May 11, 2022 Direct F1, F9
transaction SWAV Common Stock Sale -$71.4K -500 -0.34% $142.87 147K May 11, 2022 Direct F1, F10
transaction SWAV Common Stock Sale -$218K -1.5K -1.02% $145.02 146K May 11, 2022 Direct F1, F11
transaction SWAV Common Stock Sale -$205K -1.4K -0.96% $146.12 144K May 11, 2022 Direct F1, F12
transaction SWAV Common Stock Sale -$103K -700 -0.49% $147.15 144K May 11, 2022 Direct F1, F13
transaction SWAV Common Stock Sale -$104K -700 -0.49% $148.30 143K May 11, 2022 Direct F1, F14

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -15K -3.09% $0.00 470K May 11, 2022 Common Stock 15K $3.42 Direct F1, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $134.03 to $134.77. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $135.35 to $136.33. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $136.35 to $137.32. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $137.38 to $138.19. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $138.48 to $139.45. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $139.55 to $140.49. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F8 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $140.61 to $141.45. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F9 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $141.68 to $142.45 The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F10 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $142.68 to $142.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F11 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $144.48 to $145.38. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F12 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $145.55 to $146.54. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F13 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $146.79 to $147.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F14 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $147.82 to $148.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F15 Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.